nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.12.2011 | Editorial

Nuclear medicine, scientific publishing and the era of cost containment

verfasst von: Ignasi Carrió

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Excerpt

Dear readers, …

Sullivan R, Peppercorn J, Sikora K, Meropol N, Amir E, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12:933–80.PubMedCrossRef

Bockisch A. Matched pairs for radionuclide-based imaging and therapy. Eur J Nucl Med Mol Imaging. 2011;38 Suppl 1:S1–3.PubMedCrossRef

Giovacchini G, Picchio M, Coradeschi E, et al. Predictive factors of [¹¹C]choline PET/CT in patients with biochemical failure after radical prostatectomy. EJNMMI. 2010;37:301–9.

Tolmachev V, Velikyan I, Sandstrom M, et al. A HER2-binding Affibody molecule labelled with Ga-68 for PET imaging: direct in vivo comparison with the In-111-labelled analogue. EJNMMI. 2010;37:1356–67.

Dijkgraaf I, Kruijtzer JAW, Liu S, et al. Improved targeting of the alpha(v)beta(3) integrin by multimerisation of RGD peptides. EJNMMI. 2007;34:267–73.

Cai WB, Chen K, He LN, et al. Quantitative PET of EGFR expression in xenograft-bearing mice using Cu-64-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody. EJNMMI. 2007;34:850–8.

Titel: Nuclear medicine, scientific publishing and the era of cost containment
verfasst von: Ignasi Carrió
Publikationsdatum: 01.12.2011
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2011
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-011-1982-y

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2011

Certificate of Fellowship of the European Board of Nuclear Medicine 2012 Information

In vivo imaging of astrocytosis in Alzheimer’s disease: an 11C-L-deuteriodeprenyl and PIB PET study

Activity quantification combining conjugate-view planar scintigraphies and SPECT/CT data for patient-specific 3-D dosimetry in radionuclide therapy

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Tony Theobald (ed): Sampson’s textbook of radiopharmacy (4th edition)

Impact of [18F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology